3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzaldehyde

We are 3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzaldehyde CAS:151103-09-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 151103-09-2
Product Name: 3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzaldehyde
Other Name:
3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzaldehyde
4-(Difluoromethoxy)-3-(cyclopropylmethoxy)benzaldehyde
Roflumilast Impurity 9
 
Density: 1.3±0.1 g/cm3
Boiling Point: 331.3±37.0 °C at 760 mmHg
Molecular Formula: C12H12F2O3
Molecular Weight: 242.219
Flash Point: 149.1±21.4 °C
Exact Mass: 242.075455
PSA: 35.53000
LogP: 2.69
Vapour Pressure: 0.0±0.7 mmHg at 25°C
Index of Refraction: 1.529
 
Specification
Appearance: White powder
Assay: ≥99.0%
Water: ≤0.50%
 
Application
Rofluster Intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzaldehyde


Related News: The purpose of APIs according to the FDA is to cause ‘pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.3-metacriloxipropiltrimetoxisilano CAS:2530-85-0 The purpose of APIs according to the FDA is to cause ‘pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.760-94-1 This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them.2,5-DIBROMO-6-METILPIRIDINA CAS:39919-65-8 This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them.This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them.

Related Products
Product Name
4,4′-Diaminodiphenylsulfone View Details
2-Chloro-6,7-dimethoxyquinazolin-4-amine View Details
3-Methylbenzonitrile View Details
Fmoc-L-alaninol manufacturer L-Homoserine manufacturer Bromoacetyl bromide manufacturer 4-bromo-1-methyl-2-(trifluoromethyl)benzene manufacturer 4-Bromo-2-fluorobenzenesulfonamide manufacturer